Silo PharmaSILO
13F holders, Q4 2025 (December 31)15holders +1
4new positions
3sold out
$0.34avg. 13F price*
At the end of Q4 2025, 15 institutions reported holding Silo Pharma Inc. (SILO) in their 13F filings, up 1 from Q3 2025. 4 opened new positions and 3 sold out. The largest holders were AdvisorShares Investments LLC ($204K), DRW Securities, LLC ($113K) and Geode Capital Management, LLC ($32K).
- Company
- Silo Pharma Inc.
- CUSIP
- 82711P201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $144K |
| Exits | 3 | $678K |
All 13F filers, Q3 2025 → Q4 2025: 737,221 shares bought and 1,074,603 shares sold, net −337,382 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| AdvisorShares Investments LLC | 0.03% | Add +64.3% | 599,507 | $204K |
| DRW Securities, LLC | 0.01% | New | 333,733 | $113K |
| Geode Capital Management, LLC | 0.00% | Add +134.6% | 92,905 | $32K |
| XTX Topco Ltd | 0.00% | New | 56,899 | $19K |
| Jane Street Group, LLC | 0.00% | Add +104.9% | 34,373 | $12K |
| Susquehanna International Group, LLP | 0.00% | New | 29,577 | $10K |
| Vanguard Group Inc. | 0.00% | Add +48.9% | 24,321 | $8K |
| Virtu Financial LLC | 0.00% | Reduce -82.9% | 18,418 | $6K |
| State Street Corp. | 0.00% | No change | 12,500 | $4K |
| UBS Group AG | 0.00% | Reduce -32.7% | 6,043 | $2K |
| Citigroup Inc. | 0.00% | New | 3,451 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.7% | 1,695 | $576 |
| Bank of America Corp. | 0.00% | Add +44.3% | 114 | $38 |
| Westside Investment Management, Inc. | 0.00% | No change | 94 | $32 |
| Wells Fargo & Company | 0.00% | No change | 10 | $3 |
"% of holder's portfolio" is SILO's weight in each manager's 13F, not the share of Silo Pharma Inc. the manager owns.